Bio-Rad Laboratories, Inc. (NYSE:BIO.B – Get Free Report) shares rose 2.3% on Monday . The stock traded as high as $344.81 and last traded at $344.81. Approximately 11 shares were traded during trading, a decline of 99% from the average daily volume of 905 shares. The stock had previously closed at $337.08.
Bio-Rad Laboratories Stock Performance
The stock has a market cap of $9.65 billion, a P/E ratio of -12.62 and a beta of 0.72. The firm’s 50-day moving average is $336.48 and its two-hundred day moving average is $317.50. The company has a quick ratio of 4.52, a current ratio of 6.14 and a debt-to-equity ratio of 0.16.
About Bio-Rad Laboratories
Bio-Rad Laboratories, Inc manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes.
See Also
- Five stocks we like better than Bio-Rad Laboratories
- What Does a Stock Split Mean?
- Semtech Stock Climbs as AI Boom Drives Turnaround Success
- Investing In Preferred Stock vs. Common Stock
- 3 Companies Leading the Way With Aggressive Stock Buybacks
- Industrial Products Stocks Investing
- Is It Time to Buy Nuclear Energy Stocks After the Latest Dip?
Receive News & Ratings for Bio-Rad Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bio-Rad Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.
